| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 05/06/2003 | US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction |
| 05/02/2003 | EP1305305A1 Hyperpolarizable organic chromophores |
| 05/02/2003 | EP1305048A2 Inhibitors of cellular efflux pumps of microbes |
| 05/02/2003 | EP1019042B1 Anti-first-pass effect compounds |
| 05/02/2003 | EP0672047B1 ANTIALLERGIC IMIDAZO[1,2-a]THIENO[ 2,3-d]AZEPINE DERIVATIVES |
| 05/01/2003 | WO2002072581A3 Pyrazolopyriadine derivatives |
| 05/01/2003 | US20030083500 Imidazonaphthyridines |
| 04/24/2003 | WO2003033500A1 Photoactivable nitrogen bases |
| 04/24/2003 | WO2003032996A1 Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 04/24/2003 | US20030078419 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection |
| 04/24/2003 | US20030078416 Substituted phenanthrolines |
| 04/24/2003 | US20030078292 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/23/2003 | EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/23/2003 | EP1028962B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/23/2003 | CN1413213A Azaindoles |
| 04/22/2003 | US6552196 Quinolone carboxylic acid derivatives |
| 04/22/2003 | US6552049 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 04/22/2003 | US6552037 An imidazo(1,2-a)Pyridine compound useful for altering the signal-transducing activity of gamma-aminobuytric acid receptor |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/17/2003 | WO2003031405A2 Methods for the synthesis of substituted purines |
| 04/17/2003 | US20030073707 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 04/17/2003 | US20030072965 Electroluminescence device for use in display devices, backlights, electro-photographies, illumination light sources, recording light sources, exposing light sources, reading light sources, road signs and markings, optical communication |
| 04/17/2003 | CA2463507A1 Methods for the synthesis of substituted purines |
| 04/16/2003 | EP1302472A1 Molecules capable of binding to telomere and the like and method with the use of the same |
| 04/16/2003 | EP1301187A2 Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv |
| 04/15/2003 | US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | CA2296466C Alatrofloxacin parenteral compositions |
| 04/15/2003 | CA2070573C Derivatives of amide analogs of certain methano bridged quinolizines |
| 04/11/2003 | WO2004096982A2 Antibacterial agents |
| 04/10/2003 | WO2003029252A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003028732A1 Receptor antagonist |
| 04/10/2003 | WO2002048109A8 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators |
| 04/10/2003 | US20030069266 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/10/2003 | US20030069244 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | CA2430328A1 Receptor antagonist |
| 04/09/2003 | EP1299398A1 Methods and kits for the detection of arginine compounds |
| 04/09/2003 | EP1299397A1 Novel cephalosporin compounds and process for preparing the same |
| 04/09/2003 | EP1299110A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 04/09/2003 | EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 04/09/2003 | EP0902684B1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
| 04/09/2003 | EP0739345B1 Cyclic polyamines |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6544701 Reaction product, process for the production thereof, electrophotographic photoconductor using the reaction product, electrophotographic apparatus using the photoconductor, and process cartridge for electrophotographic apparatus |
| 04/08/2003 | CA2112165C Bicyclic amine derivatives |
| 04/03/2003 | US20030065023 Anticancer agents, viricides, psychological disorders |
| 04/02/2003 | EP1298062A1 Container follow-up type packaging machinery system |
| 04/02/2003 | EP1228069B1 Bicyclic and tricyclic heteroaromatic compounds |
| 04/02/2003 | EP0675887B1 Antiallergic triazolobenzazepine derivatives |
| 04/02/2003 | CN1407986A Novel imidazotriazinones and the use thereof |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1104469C Bifluorophoric perylene colourants |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. |
| 04/01/2003 | US6541483 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 04/01/2003 | CA2244508C New bis pyrido¬4,3-b carbazole compounds, their preparation process and the pharmaceutical composition containing them |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | WO2002026220A3 Taxoid conjugates as antimitotic and antitumor agents |
| 03/27/2003 | CA2460151A1 Cytokine receptor |
| 03/26/2003 | EP1294823A1 Double-spiro organic compounds and electroluminescent devices |
| 03/26/2003 | EP1294730A2 Novel cephalosporin compounds and process for preparing the same |
| 03/26/2003 | EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 03/26/2003 | EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents |
| 03/20/2003 | WO2003022856A1 Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases |
| 03/20/2003 | WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
| 03/20/2003 | WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins |
| 03/20/2003 | WO2003022274A2 2-aroylimidazole compounds for treating cancer |
| 03/20/2003 | US20030055251 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases |
| 03/20/2003 | US20030055071 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |
| 03/20/2003 | CA2460345A1 2-aroylimidazole compounds for treating cancer |
| 03/20/2003 | CA2460075A1 Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases |
| 03/20/2003 | CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins |
| 03/18/2003 | WO2002024712A1 Triazolo-epothilones |
| 03/18/2003 | US6534510 Anticoagulants |
| 03/18/2003 | CA2422500A1 Triazolo-epothilones |
| 03/18/2003 | CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes |
| 03/13/2003 | WO2003020721A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 03/13/2003 | US20030050476 Novel indolizine compound, production process for novel indolizine compound, organic light-emitting device material having indolizine skeleton, and organic light-emitting device using these |
| 03/13/2003 | US20030047719 For use as semiconductors or charge transport materials in optical, electrooptical or electronic devices including field effect transistors, electroluminescent, photovoltaics, sensors and electrophotographic recording devices |
| 03/12/2003 | EP1019426B1 Novel a1 adenosine receptor agonists and antagonists |
| 03/12/2003 | CN1402729A Polycycloalkylpurines as adenosine receptor antagonists |
| 03/11/2003 | US6531466 E.g., a 1-aza-10-(1-hydroxyethyl-11-oxo-4-(het-methylene)-tricyclo(7.2 .0.0(3,8))undec-2-ene-2-carboxylate; good activity against grampositive bacteria such as methicillin-resistant Staphylococcus aureus and epidermidis |
| 03/06/2003 | WO2003018589A1 Novel 4-aminofuropyrimidines and the use thereof |
| 03/06/2003 | WO2003018584A1 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines |
| 03/06/2003 | WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 03/06/2003 | WO2003018548A2 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof |
| 03/06/2003 | US20030045719 And optionally resolving mixture to obtain the desired enantiomer; antitumor agents |
| 03/06/2003 | US20030045542 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline |
| 03/06/2003 | US20030045540 Nicotinic acetylcholine receptors antagonists; central nervous system disorder treatments |
| 03/06/2003 | US20030045535 Antiproliferative and antitumor agents |
| 03/06/2003 | US20030045516 Chemokine receptor antagonists and methods of use therefor |
| 03/06/2003 | CA2458600A1 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis of vinblastines |
| 03/05/2003 | EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives |
| 03/05/2003 | EP1286995A1 2,7-naphthyridine derivatives |
| 03/05/2003 | CN1102595C Penems and their derivatives |
| 02/27/2003 | WO2003016561A2 Method for the production of cna |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |